Search Results - "Novikoff, Aaron"
-
1
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists
Published in Molecular metabolism (Germany) (01-07-2021)“…We assessed the spatiotemporal GLP-1 and GIP receptor signaling, trafficking, and recycling dynamics of GIPR mono-agonists, GLP-1R mono-agonists including…”
Get full text
Journal Article -
2
Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity
Published in Diabetologia (01-06-2020)“…Aims/hypothesis Treatment with the α3β4 nicotinic acetylcholine receptor (nAChR) agonist, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), improves glucose…”
Get full text
Journal Article -
3
Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice
Published in Molecular metabolism (Germany) (01-05-2024)“…The glucose-dependent insulinotropic polypeptide (GIP) decreases body weight via central GIP receptor (GIPR) signaling, but the underlying mechanisms remain…”
Get full text
Journal Article -
4
TRPM7 kinase is required for insulin production and compensatory islet responses during obesity
Published in JCI insight (08-02-2023)“…Most overweight individuals do not develop diabetes due to compensatory islet responses to restore glucose homeostasis. Therefore, regulatory pathways that…”
Get full text
Journal Article -
5
The molecular pharmacology of glucagon agonists in diabetes and obesity
Published in Peptides (New York, N.Y. : 1980) (01-07-2023)“…Within recent decades glucagon receptor (GcgR) agonism has drawn attention as a therapeutic tool for the treatment of type 2 diabetes and obesity. In both mice…”
Get full text
Journal Article -
6
Antagonizing GIPR adds fire to the GLP-1R flame
Published in Trends in endocrinology and metabolism (01-07-2024)“…Unimolecular co-agonists at the GLP-1/GIP receptors have recently achieved remarkable anti-obesogenic feats; yet, in a recent Phase 1 clinical trial, Véniant…”
Get full text
Journal Article -
7
Recent achievements and future directions of anti-obesity medications
Published in The Lancet regional health. Europe (01-12-2024)“…Pharmacological management of obesity long suffered from a reputation of a ‘Mission Impossible,’ with inefficient weight loss and/or unacceptable tolerability…”
Get full text
Journal Article -
8
Why are we still in need for novel anti-obesity medications?
Published in The Lancet regional health. Europe (01-11-2024)Get full text
Journal Article -
9
Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes
Published in Cell metabolism (01-11-2022)“…During mammalian energy homeostasis, the glucagon receptor (Gcgr) plays a key role in regulating both glucose and lipid metabolisms. However, the mechanisms by…”
Get full text
Journal Article -
10
Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes
Published in Cell metabolism (06-12-2022)Get full text
Journal Article -
11
The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
Published in Nature metabolism (01-06-2023)“…The incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) mediate insulin responses that are proportionate to…”
Get full text
Journal Article -
12
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice
Published in Nature metabolism (01-12-2023)“…The development of single-molecule co-agonists for the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIP)…”
Get full text
Journal Article -
13
Global, neuronal or β cell-specific deletion of inceptor improves glucose homeostasis in male mice with diet-induced obesity
Published in Nature metabolism (01-03-2024)“…Insulin resistance is an early complication of diet-induced obesity (DIO) 1 , potentially leading to hyperglycaemia and hyperinsulinaemia, accompanied by…”
Get full text
Journal Article -
14
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Published in Nature metabolism (01-08-2022)“…Dual agonists activating the peroxisome proliferator-activated receptors alpha and gamma (PPARɑ/ɣ) have beneficial effects on glucose and lipid metabolism in…”
Get full text
Journal Article